Eichhorst, B, Niemann, C U, Kater, A P, Fürstenau, M, von Tresckow, J, Zhang, C, Robrecht, S, Gregor, M, Juliusson, G, Thornton, P, Staber, P B, Tadmor, T, Lindström, V, da Cunha-Bang, C, Schneider, C, Poulsen, C B, Illmer, T, Schöttker, B, Nösslinger, T, Janssens, A, Christiansen, I, Baumann, M, Frederiksen, H, van der Klift, M, Jäger, U, Leys, M B L, Hoogendoorn, M, Lotfi, K, Hebart, H, Gaska, T, Koene, H, Enggaard, L, Goede, J, Regelink, J C, Widmer, A, Simon, F, De Silva, N, Fink, A-M, Bahlo, J, Fischer, K, Wendtner, C-M, Kreuzer, K A, Ritgen, M, Brüggemann, M, Tausch, E, Levin, M-D, van Oers, M, Geisler, C, Stilgenbauer, S, Hallek, M, German CLL Study Group (GCLLSG), Haemato-Oncology Foundation for Adults in the Netherlands (HOVON), Nordic CLL Study Groups, Swiss Group for Clinical Cancer Research (SAKK), The Israeli CLL Association & Cancer Trials Ireland 2023, ' First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia ', The New England Journal of Medicine, vol. 388, no. 19, pp. 1739-1754 . https://doi.org/10.1056/NEJMoa2213093
Tausch, E, Schneider, C, Furstenau, M, Robrecht, S, Yosifov, D Y, Mertens, D, Gregor, M, Thornton, P, Staber, P B, Tadmor, T, Levin, M-D, da Cunha-Bang, C, Poulsen, C B, Illmer, T, Schöttker, B, Janssens, A, Christiansen, I, Noesslinger, T, Baumann, M, Wendtner, C-M, Eldering, E, Kreuzer, K-A, Ritgen, M, Fink, A-M, Fischer, K, Kater, A P, Niemann, C U, Hallek, M, Eichhorst, B & Stilgenbauer, S 2022, ' Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment-Outcome Results from the CLL13/GAIA Trial ', Blood, vol. 140, no. Suppl. 1, 642, pp. 839–841 . https://doi.org/10.1182/blood-2022-163775